Autres langues Quanterix Corporation

Actions

QTRX

US74766Q1013

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
15,76 ^USD	-3,67 %		+18,67 %	-42,36 %

12/06	Transcript : Quanterix Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:40 PM
08/05	Transcript : Quanterix Corporation, Q1 2024 Earnings Call, May 08, 2024

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Quanterix to Participate at the Scotiabank Healthcare 1x1 Day	17/06
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference	05/06
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024	22/05
Quanterix Corporation Announces Resignation of Brian J. Blaser from its Board of Directors	07/05
Earnings Flash (QTRX) QUANTERIX CORPORATION Posts Q1 Revenue $32.1M, vs. Street Est of $31.5M	07/05
Quanterix Releases Financial Results for the First Quarter of 2024	07/05
Quanterix Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Quanterix Corporation Provides Earnings Guidance for the Full-Year 2024	07/05
Quanterix To Report First Quarter 2024 Financial Results	29/04
Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election	12/04
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure	21/03
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease	04/03
Quanterix Corporation Receives Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer?s Disease	04/03
Quanterix Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Quanterix Corporation Provides Earnings Guidance for the Year 2024	29/02
Quanterix Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Earnings Flash (QTRX) QUANTERIX CORPORATION Reports Q4 Revenue $31.5M, vs. Street Est of $29.8M	29/02
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023	29/02
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance	27/02
Quanterix Corporation Reaffirms Earnings Guidance for the Year 2023	27/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Quanterix Corporation

Actions

QTRX

US74766Q1013

Autres langues

Filtres